Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spotlight on the NLRP3 inflammasome pathway
Marine Groslambert, Bénédicte F. Py
Journal of Inflammation Research (2018) Vol. Volume 11, pp. 359-374
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

The lncRNA Neat1 promotes activation of inflammasomes in macrophages
Pengfei Zhang, Limian Cao, Rongbin Zhou, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 390
Ubiquitination in the regulation of inflammatory cell death and cancer
Peter E. Cockram, Matthias Kist, Sumit Prakash, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 591-605
Open Access | Times Cited: 310
Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease
Kaimin Zhang, Chun Fan, Dongpeng Cai, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 203
Fatigue, Sleep, and Autoimmune and Related Disorders
Mark R. Zielinski, David M. Systrom, Noel R. Rose
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 189
A Bibliometric Analysis of Pyroptosis From 2001 to 2021
Dan Ma, Bin Yang, Baoyi Guan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 171
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
Mariusz Z. Ratajczak, Kamila Bujko, Andrzej K. Ciechanowicz, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 266-277
Open Access | Times Cited: 164
Role of pyroptosis in spinal cord injury and its therapeutic implications
Abdullah Al Mamun, Yanqing Wu, Ilma Monalisa, et al.
Journal of Advanced Research (2020) Vol. 28, pp. 97-109
Open Access | Times Cited: 164
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
Dobromir Dobrev, Jordi Heijman, Roddy Hiram, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 3, pp. 145-167
Open Access | Times Cited: 151
The NLRP3 inflammasome in depression: Potential mechanisms and therapies
Cong‐Yuan Xia, Yuxuan Guo, Wenwen Lian, et al.
Pharmacological Research (2022) Vol. 187, pp. 106625-106625
Open Access | Times Cited: 79
IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network
Niklas A. Schmacke, Fionan O’Duill, Moritz M. Gaidt, et al.
Immunity (2022) Vol. 55, Iss. 12, pp. 2271-2284.e7
Open Access | Times Cited: 77
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Juraj Velcicky, Philipp Janser, Nina Gommermann, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1544-1562
Closed Access | Times Cited: 19
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2
Francis L. Poe, Joshua Corn
Medical Hypotheses (2020) Vol. 143, pp. 109862-109862
Open Access | Times Cited: 125
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Sunny Malhotra, Carme Costa, Herena Eixarch, et al.
Brain (2020) Vol. 143, Iss. 5, pp. 1414-1430
Open Access | Times Cited: 115
NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Ilona M. Góra, Anna Ciechanowska, Piotr Ładyżyński
Cells (2021) Vol. 10, Iss. 2, pp. 314-314
Open Access | Times Cited: 98
Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation
Bo‐Zong Shao, Shuling Wang, Peng Pan, et al.
Inflammation (2019) Vol. 42, Iss. 4, pp. 1147-1159
Closed Access | Times Cited: 92
The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
Mariusz Z. Ratajczak, Kamila Bujko, Monika Cymer, et al.
Leukemia (2020) Vol. 34, Iss. 6, pp. 1512-1523
Open Access | Times Cited: 87
Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury
Mick Frissen, Lijun Liao, Kai Markus Schneider, et al.
Hepatology (2020) Vol. 73, Iss. 5, pp. 1836-1854
Open Access | Times Cited: 76
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart
Anke C. Fender, S Kleeschulte, Svenja Stolte, et al.
Basic Research in Cardiology (2020) Vol. 115, Iss. 2
Open Access | Times Cited: 75
High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression
Jing Wang, Xuefang Shen, Jing Liu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 71
Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in mice
Océane Dufies, Anne Doye, Johan Courjon, et al.
Nature Microbiology (2021) Vol. 6, Iss. 3, pp. 401-412
Open Access | Times Cited: 62
Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro
Dai-Chao Ma, Nannan Zhang, Yina Zhang, et al.
Journal of Ethnopharmacology (2021) Vol. 270, pp. 113776-113776
Closed Access | Times Cited: 60
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
Santosh Suryavanshi, Igor Kovalchuk, Olga Kovalchuk
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 57
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Julia Barczuk, Natalia Siwecka, Weronika Lusa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8979-8979
Open Access | Times Cited: 46
RAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
Oualid Sbai, Mehdi Djelloul, Antonia Auletta, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 41
Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation
Pin‐Yu Chen, Jiin‐Cherng Yen, Tzu-Ting Liu, et al.
Brain (2023) Vol. 146, Iss. 7, pp. 2989-3002
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top